Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
OnkoSight Advanced Bladder Cancer Panel BioReference Laboratories United States | 1 | 39 |
|
OnkoSight Advanced Breast Cancer Panel BioReference Laboratories United States | 1 | 50 |
|
BioReference Laboratories United States | 1 | 75 |
|
BioReference Laboratories United States | 1 | 1 |
|
POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE BioReference Laboratories United States | 1 | 1 |
|
BioReference Laboratories United States | 1 | 1 |
|
BioReference Laboratories United States | 1 | 1 |
|
ALPORT SYNDROME, AUTOSOMAL RECESSIVE BioReference Laboratories United States | 1 | 1 |
|
BioReference Laboratories United States | 1 | 1 |
|
CARNITINE PALMITOYLTRANSFERASE DEFICIENCY, TYPE 2 BioReference Laboratories United States | 1 | 1 |
|
BioReference Laboratories United States | 1 | 1 |
|
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA BioReference Laboratories United States | 1 | 1 |
|
DEAFNESS, AUTOSOMAL RECESSIVE 1A BioReference Laboratories United States | 1 | 1 |
|
FACTOR XI DEFICIENCY (HEMOPHILIA C) BioReference Laboratories United States | 1 | 1 |
|
BioReference Laboratories United States | 1 | 1 |
|
BioReference Laboratories United States | 1 | 1 |
|
OnkoSight Advanced Plasma Cell Myeloma NGS Panel BioReference Laboratories United States | 1 | 50 |
|
OnkoSight Advanced Prostate NGS BioReference Laboratories United States | 1 | 34 |
|
OnkoSight Advanced Solid Tumor NGS BioReference Laboratories United States | 1 | 50 |
|
OnkoSight Advanced Pancreatic & Biliary Tract NGS BioReference Laboratories United States | 1 | 22 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.